Fred Saad, MD
Enriched profileUro-oncologist and Chief, Department of Urology, CHUM; Director, Prostate Cancer Research, Montreal Cancer Institute/CRCHUM; Full Professor, Department of Surgery, Université de Montréal; Holder of the Raymond Garneau Chair in Prostate Cancer Research · Centre hospitalier de l'Université de Montréal (CHUM)
Fred Saad is Uro-oncologist and Chief, Department of Urology, CHUM; Director, Prostate Cancer Research, Montreal Cancer Institute/CRCHUM; Full Professor, Department of Surgery, Université de Montréal; Holder of the Raymond Garneau Chair in Prostate Cancer Research at Centre hospitalier de l'Université de Montréal (CHUM). OpenAlex indexes 1,915 publications with 109,700 citations (h-index 128); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Fred Saad is Uro-oncologist and Chief, Department of Urology, CHUM at Centre hospitalier de l'Université de Montréal (CHUM) / CRCHUM (CHUM Research Centre). The public record shows 1,915 publications with 109,700 citations (h-index 128), centered on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications. It also documents an investigator role on 7 registered clinical trials.
- Most recent indexed publication: 2026 · BJU international
- Top research focus: Prostate Cancer Treatment and Research
- 7 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 85 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 776.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Institut du cancer de Montréal, 900 rue St-Denis, 10th floor, Montréal, QC H2X 0A9
Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
Sponsor: Canadian Cancer Trials Group
- Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- 131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.
Clinical cancer research
Clinical Trial2026 - Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.
Journal of clinical oncology
Clinical Trial2026 - Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.
JCO precision oncology
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy4,583 citations2012
- 02Abiraterone and Increased Survival in Metastatic Prostate Cancer4,400 citations2011
- 03Enzalutamide in Metastatic Prostate Cancer before Chemotherapy3,036 citations2014
- 04Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy2,796 citations2012
- 05Olaparib for Metastatic Castration-Resistant Prostate Cancer2,246 citations2020
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Fred-Saad
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/chum.montreal/posts/-cancer-de-la-prostate-dr-fred-saad-a-dirig%C3%A9-une-%C3%A9quipe-internationale-qui-a-tes/10160141294036807
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/chum.montreal/posts/il-a-aid%C3%A9-%C3%A9norm%C3%A9ment-dhommes-%C3%A0-d%C3%A9mystifier-le-cancer-de-la-prostate-%C3%A0-comprendre/10158151783776807
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
icm.qc.ca/author/fred-saad
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →icm.qc.ca ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗
- FRSC (Fellow of the Royal Society of Canada)
distinct from FCAHS; confirmed independently via ICM institutional page and corroborating search results, not captured in the CHUM primary page's credential list
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →icm.qc.ca ↗ - CQ (Chevalier de l'Ordre national du Québec / Knight of the National Order of Quebec)
honorific, not a degree
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗
Editorial & leadership roles
journal and society appointments- President
Canadian Urologic Oncology Group (CUOG) and National Cancer Institute of Canada G-U (NCIC G-U)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗ - Secretary
Canadian Prostate Health Council and Global G-U
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗
Awards & honors
honors on the public record- Knight of the National Order of Quebec (Chevalier de l'Ordre national du Québec)
invested June 22, 2018, the highest honor given by the Quebec government
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ordre-national.gouv.qc.ca ↗ - Lifetime Achievement Award
CHUM Research Center (CRCHUM)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cqc-qcc.ca ↗ - Lifetime Achievement Award
Quebec Urologic Association (Association des urologues du Québec)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cqc-qcc.ca ↗
Secondary affiliations
appointments beyond the home institution- Founder
Oncology Urology Clinic, CHUM
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗ - Founder
Molecular Oncology Laboratory in Prostate Cancer, Institut du cancer de Montréal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chumontreal.qc.ca ↗ - Board Member
Institut du cancer de Montréal (15+ years)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →icm.qc.ca ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urologytimes.com ↗
- YouTube (CRCHUM-related content): "Dr Fred Saad – La recherche clinique en cancer de la prostate au CRCHUM"
chef de l'unité d'urologie au CHUM, corroborated by companion CRCHUM Facebook post
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - CHUM Facebook video: public information evening on prostate cancer featuring Dr. Fred Saad
interviewed by Pierre (CHUM patient-education event)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Peter Carroll, MD
University of California, San Francisco